Response of Regenerative Therapy in Non-Hair Treatment Patients with Androgenetic Alopecia Approved for Hairmetrix Technology - Case Report

    September 2025 in “ Journal of Dermatology Research Reviews & Reports ”
    Filipe Kawakami Duarte Da Silva
    Studysummary This study found that men aged 33 to 44 with androgenetic alopecia experienced significant hair improvement over 7 months after treatment with autologous cells using the Rigenera® system, as evaluated by HairMetrix® technology.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Platelet-Rich Plasma for Hair Loss Springer eBooks · 2021
    2. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil, Finasteride, and Adult Stem Cell-Based Therapy International Journal of Molecular Sciences · 2020
    3. Androgenetic Alopecia: A Review Endocrine · 2017